GlassScriptPhysician profile
Helia Eragi
NPI 1013283910
$2,151.28
in general payments reported to CMS, 2019-2025
16 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $115 · 2021: $406 · 2022: $164 · 2023: $170 · 2024: $246 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $563.49 | 2021-2025 | Aklief, Nemluvio |
| Novartis Pharmaceuticals Corporation | $444.74 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $156.01 | 2019 | |
| Allergan, INC. | $129.59 | 2019 | |
| Botanix Sb INC | $129.11 | 2025 | Sofdra |
| Incyte Corporation | $117.27 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $89.98 | 2021 | |
| Lilly USA, LLC | $86.29 | 2019-2022 | |
| Pfizer INC. | $85.22 | 2019-2021 | |
| Abbvie INC. | $72.68 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $67.18 | 2019-2021 | |
| Stemline Therapeutics INC. | $57.11 | 2021 | |
| Amgen INC. | $53.29 | 2020-2023 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.48 | 2022 | |
| Dermira, INC. | $34.06 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $25.78 | 2025 | Recell, Permeaderm, Cohealyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helia Eragi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.